Hit optimization by dynamic combinatorial chemistry on Streptococcus pneumoniae energy-coupling factor transporter
Ioulia Antonia Exapicheidou1,2, Atanaz Shams1,2, Hamza Ibrahim3
1Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), 66123, Saarbrücken, Germany. anna.hirsch@helmholtz-hips.de.
We used target-directed dynamic combinatorial chemistry (tdDCC) to discover new inhibitors for the ECF-PanT transporter in Streptococcus pneumoniae. This method identified optimized compounds with improved activity and revealed their binding interactions.
Area of Science:
- Biochemistry and structural biology
- Microbiology
- Medicinal chemistry
Background:
- The energy-coupling factor (ECF) transporter ECF-PanT in Streptococcus pneumoniae is a highly dynamic transmembrane complex.
- Targeted drug discovery is crucial for developing new antimicrobial agents.
Purpose of the Study:
- To apply target-directed dynamic combinatorial chemistry (tdDCC) for the first time to the ECF-PanT transporter.
- To identify and optimize inhibitors of ECF-PanT using tdDCC.
- To characterize the identified inhibitors and elucidate their binding mode.
Main Methods:
- Application of target-directed dynamic combinatorial chemistry (tdDCC).
- Hit identification and optimization strategy.
- Cytotoxicity characterization of lead compounds.
- Computational modeling and docking studies on the ECF-PanT crystal structure.
Main Results:
- Successful application of tdDCC to the ECF-PanT complex.
- Identification of optimized ECF inhibitors with enhanced activity.
- Characterization of compound cytotoxicity.
- Computational analysis rationalizing inhibitor binding modes, highlighting the role of the acylhydrazone linker.
Conclusions:
- tdDCC is an effective strategy for discovering and optimizing inhibitors of dynamic protein complexes like ECF-PanT.
- The identified inhibitors show promising activity and favorable binding interactions.
- Further development of these inhibitors could lead to novel therapeutic agents against Streptococcus pneumoniae infections.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:53Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
Published on: October 2, 2017
Related Concept Videos
Catalytically Perfect Enzymes
Other Glycolytic Pathways
Chemotaxis in E. coli
Stringent Response in E. coli
